Your session is about to expire
← Back to Search
Phosphodiesterase type 5 inhibitor
1 for Erectile Dysfunction (HBOT Trial)
Phase 4
Waitlist Available
Led By James Graydon, MD
Research Sponsored by Hartford Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 10 years
Awards & highlights
HBOT Trial Summary
The purpose of this study is to determine if adding hyperbaric oxygen therapy, a therapy that delivers oxygen under slight pressure, to a drug treatment of PDE5I (such as Viagra, Levitra, Cialis)for men following surgery for prostate cancer will result in more men being able to continue to have erections.
Eligible Conditions
- Erectile Dysfunction
- Prostate Cancer
HBOT Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 10 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 10 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Erectile function domain of Internation Index of Erectile Function (IIEF)
Secondary outcome measures
clinical or biochemical recurrence of cancer
HBOT Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: 1Active Control1 Intervention
Group II: 2Placebo Group1 Intervention
Find a Location
Who is running the clinical trial?
Hartford HospitalLead Sponsor
133 Previous Clinical Trials
18,832 Total Patients Enrolled
James Graydon, MDPrincipal InvestigatorHartford Hospital
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger